Effective induction of anti-tumor immune responses with oligomannose-coated liposome targeting to intraperitoneal phagocytic cells

Cancer Letters

Volumn 260, Issue 1-2, 2008, Pages 137-145

  Ikehara, Yuzuru ^a,b   Shiuchi, Nobumitsu ^c   Kabata Ikehara, Sanae ^a,b   Nakanishi, Hayao ^b   Yokoyama, Naoaki ^d   Takagi, Hideaki ^c   Nagata, Toshi ^e   Koide, Yukio ^e   Kuzushima, Kiyotaka ^b   Takahashi, Toshitada ^f   Tsujimura, Kunio ^e   Kojima, Naoya ^c  

^a NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^b AICHI CANCER CENTER HOSPITAL   (Japan)

^c TOKAI UNIVERSITY   (Japan)

^d OBIHIRO UNIVERSITY OF AGRICULTURE AND VETERINARY MEDICINE   (Japan)

^e HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f Aichi Health Promotion Foundation   (Japan)

Author keywords

Cancer vaccine; Drug delivery system; Immune responses to cancer; Oligomannose liposome

Indexed keywords

CHOLESTEROL; DIPALMITOYLPHOSPHATIDYLCHOLINE; FLUORESCEIN ISOTHIOCYANATE; GAMMA INTERFERON; LIPOSOME; MANNOSE; OLIGOMANNOSE; OVALBUMIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN SPECIFICITY; ARTICLE; CANCER IMMUNOTHERAPY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DRUG DELIVERY SYSTEM; FEMALE; FLOW CYTOMETRY; IMMUNE RESPONSE; IMMUNIZATION; MOUSE; NONHUMAN; PERITONEAL CAVITY; PERITONEUM MACROPHAGE; PHAGOCYTOSIS; PRIORITY JOURNAL; TRANSGENIC MOUSE; TUMOR IMMUNOLOGY;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD11B; ANTIGENS, DIFFERENTIATION; CELL LINE, TUMOR; CELL MOVEMENT; DRUG CARRIERS; DRUG COMPOUNDING; EGG PROTEINS; FEMALE; H-2 ANTIGENS; HISTOCOMPATIBILITY ANTIGENS CLASS II; IMMUNODOMINANT EPITOPES; IMMUNOTHERAPY; LIPOSOMES; LYMPHOCYTE ACTIVATION; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; OVALBUMIN; PEPTIDE FRAGMENTS; PHAGOCYTOSIS; T-LYMPHOCYTES, CYTOTOXIC; T-LYMPHOCYTES, HELPER-INDUCER; THYMOMA; THYMUS NEOPLASMS; TRANSFECTION; TRISACCHARIDES;

MUS;

EID: 38349056673     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2007.10.038     Document Type: Article

References (31)

1. Gattinoni L., Powell Jr. D.J., Rosenberg S.A., and Restifo N.P. Adoptive immunotherapy for cancer: building on success. Nat. Rev. Immunol. 6 (2006) 383-393
2. Rosenberg S.A., Yang J.C., and Restifo N.P. Cancer immunotherapy: moving beyond current vaccines. Nat. Med. 10 (2004) 909-915
3. Rosenberg S.A. Progress in the development of immunotherapy for the treatment of patients with cancer. J. Intern. Med. 250 (2001) 462-475
4. Boon T., Coulie P.G., Van den Eynde B.J., and van der Bruggen P. Human T cell responses against melanoma. Annu. Rev. Immunol. 24 (2006) 175-208
5. Pardoll D.M., and Topalian S.L. The role of CD4+ T cell responses in antitumor immunity. Curr. Opin. Immunol. 10 (1998) 588-594
6. Wang R.F., Peng G., and Wang H.Y. Regulatory T cells and toll-like receptors in tumor immunity. Semin. Immunol. 18 (2006) 136-142
7. Sakaguchi S., Setoguchi R., Yagi H., and Nomura T. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in self-tolerance and autoimmune disease. Curr. Top. Microbiol. Immunol. 305 (2006) 51-66
8. Leen A.M., Rooney C.M., and Foster A.E. Improving T cell therapy for cancer. Annu. Rev. Immunol. 25 (2007) 243-265
9. Ikehara Y., and Kojima N. Development of a novel oligomannose-coated liposome-based anticancer drug-delivery system for intraperitoneal cancer. Curr. Opin. Mol. Ther. 9 (2007) 53-61
10. Ikehara Y., Niwa T., Biao L., Ikehara S.K., Ohashi N., Kobayashi T., Shimizu Y., Kojima N., and Nakanishi H. A carbohydrate recognition-based drug delivery and controlled release system using intraperitoneal macrophages as a cellular vehicle. Cancer Res. 66 (2006) 8740-8748
11. Krist L.F., Kerremans M., Broekhuis-Fluitsma D.M., Eestermans I.L., Meyer S., and Beelen R.H. Milky spots in the greater omentum are predominant sites of local tumour cell proliferation and accumulation in the peritoneal cavity. Cancer Immunol. Immunother. 47 (1998) 205-212
12. Hagiwara A., Takahashi T., Sawai K., Taniguchi H., Shimotsuma M., Okano S., Sakakura C., Tsujimoto H., Osaki K., Sasaki S., et al. Milky spots as the implantation site for malignant cells in peritoneal dissemination in mice. Cancer Res. 53 (1993) 687-692
13. Hogquist K.A., Jameson S.C., Heath W.R., Howard J.L., Bevan M.J., and Carbone F.R. T cell receptor antagonist peptides induce positive selection. Cell 76 (1994) 17-27
14. Clarke S.R., Barnden M., Kurts C., Carbone F.R., Miller J.F., and Heath W.R. Characterization of the ovalbumin-specific TCR transgenic line OT-I: MHC elements for positive and negative selection. Immunol. Cell Biol. 78 (2000) 110-117
15. Barnden M.J., Allison J., Heath W.R., and Carbone F.R. Defective TCR expression in transgenic mice constructed using cDNA-based alpha- and beta-chain genes under the control of heterologous regulatory elements. Immunol. Cell Biol. 76 (1998) 34-40
16. Moore M.W., Carbone F.R., and Bevan M.J. Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell 54 (1988) 777-785
17. Gorer P.A. Studies in antibody response of mice to tumour inoculation. Br. J. Cancer 4 (1950) 372-379
18. Mizuochi T., Loveless R.W., Lawson A.M., Chai W., Lachmann P.J., Childs R.A., Thiel S., and Feizi T. A library of oligosaccharide probes (neoglycolipids) from N-glycosylated proteins reveals that conglutinin binds to certain complex-type as well as high mannose-type oligosaccharide chains. J. Biol. Chem. 264 (1989) 13834-13839
19. Tai T., Yamashita K., Ogata-Arakawa M., Koide N., Muramatsu T., Iwashita S., Inoue Y., and Kobata A. Structural studies of two ovalbumin glycopeptides in relation to the endo-beta-N-acetylglucosaminidase specificity. J. Biol. Chem. 250 (1975) 8569-8575
20. Tan M.C., Mommaas A.M., Drijfhout J.W., Jordens R., Onderwater J.J., Verwoerd D., Mulder A.A., van der Heiden A.N., Ottenhoff T.H., Cella M., Tulp A., Neefjes J.J., and Koning F. Mannose receptor mediated uptake of antigens strongly enhances HLA-class II restricted antigen presentation by cultured dendritic cells. Adv. Exp. Med. Biol. 417 (1997) 171-174
21. Lanzavecchia A. Mechanisms of antigen uptake for presentation. Curr. Opin. Immunol. 8 (1996) 348-354
22. Sallusto F., Cella M., Danieli C., and Lanzavecchia A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J. Exp. Med. 182 (1995) 389-400
23. Lam J.S., Mansour M.K., Specht C.A., and Levitz S.M. A model vaccine exploiting fungal mannosylation to increase antigen immunogenicity. J. Immunol. 175 (2005) 7496-7503
24. Shimizu Y., Yamakami K., Gomi T., Nakata M., Asanuma H., Tadakuma T., and Kojima N. Protection against Leishmania major infection by oligomannose-coated liposomes. Bioorg. Med. Chem. 11 (2003) 1191-1195
25. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 3 (2003) 133-146
26. Martinez F.O., Gordon S., Locati M., and Mantovani A. Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J. Immunol. 177 (2006) 7303-7311
27. Gordon S. Alternative activation of macrophages. Nat. Rev. Immunol. 3 (2003) 23-35
28. Mantovani A., Sica A., and Locati M. Macrophage polarization comes of age. Immunity 23 (2005) 344-346
29. Mantovani A., Sica A., Sozzani S., Allavena P., Vecchi A., and Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 25 (2004) 677-686
30. Stein M., Keshav S., Harris N., and Gordon S. Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J. Exp. Med. 176 (1992) 287-292
31. Cannistra S.A. Intraperitoneal chemotherapy comes of age. N. Engl. J. Med. 354 (2006) 77-79